Nuclear Medicine & Radiation Therapy

ISSN: 2155-9619

Open Access

Lowell Anthony

FACP, New Orleans, LA

  • Special Issue Article
    Neuroendocrine Hepatic Tumors: Summary of Patient Selection, Response and Toxicity of Radioembolization in 281 Patients
    Author(s): Lowell AnthonyLowell Anthony

    Debulking neuroendocrine hepatic metastases is commonplace as both symptoms and disease are better controlled. The challenge in clinical decision making includes patient selection, timing and procedure. Extirpation, radiofrequency ablation, hepatic artery chemoembolization, bland embolization and radioembolization are techniques widely available in the U.S. For patients undergoing intrahepatic therapies, procedure selection is based not only on disease bulk but also on disease location. From 8 published studies, the outcomes of 281 patients who underwent radioembolization were reviewed. Symptomatic improvement occurs within 3 months in approximately half the patients. Partial biochemical responses (>50% reduction from baseline) using chromogranin A occur in two thirds of subjects as 2 centers have observed. Disease control (complete + partial + stable responses) is reported in 50-1.. Read More»
    DOI: 10.4172/2155-9619.1000104

    Abstract PDF

Relevant Topics

Google Scholar citation report
Citations: 570

Nuclear Medicine & Radiation Therapy received 570 citations as per Google Scholar report

Nuclear Medicine & Radiation Therapy peer review process verified at publons

Indexed In

arrow_upward arrow_upward